NeuroPace
NPCE70
$14.68arrow_drop_up3.99%$0.56
High Growth
NPCE70
$14.68
arrow_drop_up3.99%| Key Stats | |
|---|---|
| Open | $14.02 |
| Prev. Close | $14.02 |
| EPS | -0.98 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 13.44 | 15.19 |
| 52 Week Range | 5.75 | 18.15 |
| Ratios | |
|---|---|
| EPS | -0.98 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.90% |
| Last Dividend pay date | - |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
NPCE-
US Healthcare Sector-
US Market-
check_circle
NPCE / Market
NPCE exceeded the US Market which returned 0.66% over the last twenty four hours.check_circle
NPCE / Healthcare Sector
NPCE exceeded the US Healthcare sector which returned 2.53% over the last twenty four hours.NeuroPace (NPCE) Statistics
Keep an eye on NeuroPace
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has NeuroPace (NPCE) stock's performance compared to its sector and the market over the past year?
Over the past year, NeuroPace (NPCE) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 22.58%, NeuroPace has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.22%, it has fallen short of the market average. This comparison highlights NeuroPace's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of NeuroPace (NPCE) stock?
The PE ratio for NeuroPace (NPCE) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of NeuroPace (NPCE) stock?
The Earnings Per Share (EPS) for NeuroPace (NPCE), calculated on a diluted basis, is -$0.98. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of NeuroPace (NPCE) stock?
The operating margin for NeuroPace (NPCE) is -20.15%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of NeuroPace (NPCE) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of NeuroPace (NPCE) is -$22.87M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does NeuroPace (NPCE) have?
NeuroPace (NPCE) has a total debt of $73.5M. The net debt, which accounts for cash and cash equivalents against the total debt, is $58.08M.